HEATHER WALLACE: Open Payments
NPI 1962993634 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 22 payments from 12 companies in 2025. Trend: 2023 $373 · 2024 $415 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $85 |
| Novo Nordisk Inc | 4 | $75 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| ABBVIE INC. | 3 | $51 |
| Lilly USA, LLC | 2 | $45 |
| Abbott Laboratories | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: GEMTESA, QULIPTA, MOUNJARO, Rybelsus, NURTEC ODT, ELIQUIS, FREESTYLE LIBRE 3, Yeztugo.
Industry payments across SC — which companies pay providers there.
